These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10788680)

  • 21. Serotonergic function in major depression and effect of sertraline and paroxetine treatment.
    Stain-Malmgren R; Khoury AE; Aberg-Wistedt A; Tham A
    Int Clin Psychopharmacol; 2001 Mar; 16(2):93-101. PubMed ID: 11236074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains.
    Rosel P; Arranz B; Vallejo J; Oros M; Menchón JM; Alvarez P; Navarro MA
    J Neural Transm (Vienna); 1997; 104(8-9):921-9. PubMed ID: 9451724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding.
    Wihlbäck AC; Sundström Poromaa I; Bixo M; Allard P; Mjörndal T; Spigset O
    Psychoneuroendocrinology; 2004 Jul; 29(6):757-66. PubMed ID: 15110925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet [3H]paroxetine binding, 5-HT-stimulated Ca2+ response, and 5-HT content in winter seasonal affective disorder.
    Ozaki N; Rosenthal NE; Mazzola P; Chiueh CC; Hardin T; Garcia-Borreguero D; Schwartz PJ; Turner E; Oren DA; Murphy DL
    Biol Psychiatry; 1994 Oct; 36(7):458-66. PubMed ID: 7811842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonergic activity measured by platelet [3H]paroxetine binding in patients with eating disorders.
    Ramacciotti CE; Coli E; Paoli R; Marazziti D; Dell'Osso L
    Psychiatry Res; 2003 May; 118(1):33-8. PubMed ID: 12759159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
    Alvarez JC; Gluck N; Arnulf I; Quintin P; Leboyer M; Pecquery R; Launay JM; Perez-Diaz F; Spreux-Varoquaux O
    Clin Pharmacol Ther; 1999 Dec; 66(6):617-24. PubMed ID: 10613618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative symptoms of schizophrenia are improved by paroxetine added to neuroleptics: a pilot study.
    Jockers-Scherübl M; Godemann F; Pietzcker A
    J Clin Psychiatry; 2001 Jul; 62(7):573. PubMed ID: 11488373
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet serotonin measures in adolescents with conduct disorder.
    Unis AS; Cook EH; Vincent JG; Gjerde DK; Perry BD; Mason C; Mitchell J
    Biol Psychiatry; 1997 Oct; 42(7):553-9. PubMed ID: 9376451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patients.
    Marazziti D; Conti L; Pfanner C; Presta S; Rossi A; Gemignani A; Dell'Osso L; Cassano GB
    Neuropsychobiology; 2001; 43(3):117-22. PubMed ID: 11287787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-lasting inhibition of 5-HT uptake of platelets in subjects treated by duloxetine, a potential antidepressant.
    Kasahara T; Ishigooka J; Nagata E; Murasaki M; Miura S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Feb; 16(1):25-31. PubMed ID: 8640460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of antidepressant drugs in schizophrenic patients with depression].
    Micallef J; Fakra E; Blin O
    Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria.
    Melke J; Westberg L; Landén M; Sundblad C; Eriksson O; Baghei F; Rosmond R; Eriksson E; Ekman A
    Psychoneuroendocrinology; 2003 Apr; 28(3):446-58. PubMed ID: 12573307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition and dissociation of [3H]-paroxetine binding to human platelets.
    Andersson A; Marcusson J
    Neuropsychobiology; 1989; 22(3):135-40. PubMed ID: 2535005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients.
    Marazziti D; Rossi A; Gemignani A; Giannaccini G; Pfanner C; Milanfranchi A; Presta S; Lucacchini A; Cassano GB
    Neuropsychobiology; 1996; 34(4):184-7. PubMed ID: 9121618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
    Spigset O; Allard P; Mjörndal T
    Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased platelet peripheral-type benzodiazepine receptors in persistently violent schizophrenia patients.
    Ritsner M; Modai I; Gibel A; Leschiner S; Silver H; Tsinovoy G; Weizman A; Gavish M
    J Psychiatr Res; 2003; 37(6):549-56. PubMed ID: 14563387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of citalopram treatment on platelet serotonin function in panic disorders.
    Neuger J; Wistedt B; Sinner B; Aberg-Wistedt A; Stain-Malmgren R
    Int Clin Psychopharmacol; 2000 Mar; 15(2):83-91. PubMed ID: 10759339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder.
    Ruhé HG; Ooteman W; Booij J; Michel MC; Moeton M; Baas F; Schene AH
    Pharmacogenet Genomics; 2009 Jan; 19(1):67-76. PubMed ID: 18987562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased platelet 3H-paroxetine binding in untreated panic disorder patients.
    Marazziti D; Rossi A; Dell'Osso L; Palego L; Placidi GP; Giannaccini G; Lucacchini A; Cassano GB
    Life Sci; 1999; 65(25):2735-41. PubMed ID: 10622283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the serotonin transporter in platelets.
    Langer SZ; Galzin AM
    Experientia; 1988 Feb; 44(2):127-30. PubMed ID: 2964377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.